Further studies in serum enzyme activity during split-course radiotherapy of malignant tumours.
D002813:Chondrosarcoma / Q000532:radiotherapy; D003110:Colonic Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D004938:Esophageal Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008113:Liver Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D008175:Lung Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D008223:Lymphoma / Q000201:enzymology / Q000532:radiotherapy; D008479:Mediastinal Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D009369:Neoplasms / Q000201:enzymology* / Q000532:radiotherapy*; D010190:Pancreatic Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012004:Rectal Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D013274:Stomach Neoplasms / Q000201:enzymology / Q000532:radiotherapy; D001749:Urinary Bladder Neoplasms / Q000201:enzymology / Q000532:radiotherapy
D007770:L-Lactate Dehydrogenase; D005634:Fructose-Bisphosphate Aldolase